ProShares UltraShort NASDAQ Biotechnology
10 hedge funds and large institutions have $3.06M invested in ProShares UltraShort NASDAQ Biotechnology in 2019 Q2 according to their latest regulatory filings, with 3 funds opening new positions, 1 increasing their positions, 5 reducing their positions, and 1 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more ownership
Funds ownership: →
less capital invested
Capital invested by funds: $ → $
80% less repeat investments, than reductions
Existing positions increased: 1 | Existing positions reduced: 5
Holders
10
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$426K | |
| 2 | +$359K | |
| 3 | +$9.6K | |
| 4 |
Simplex Trading
Chicago,
Illinois
|
+$5K |
Top Sellers
| 1 | -$608K | |
| 2 | -$319K | |
| 3 | -$247K | |
| 4 |
Citadel Advisors
Miami,
Florida
|
-$44.9K |
| 5 |
UBS Group
Zurich,
Switzerland
|
-$25.4K |